Pnc Financial Services Group, Inc. Amicus Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$162 Billion
Q3 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 450 shares of FOLD stock, worth $4,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares

450

Previous 232 93.97%

Holding current value

$4,266

Previous $1,000 200.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$5.84 - $8.57 $1,273 - $1,868	218 Added 93.97%	450 $3,000
Q2 2025 Aug 08, 2025	SELL	$5.64 - $8.0 $27,743 - $39,352	-4,919 Reduced 95.5%	232 $1,000
Q1 2025 May 09, 2025	BUY	$8.16 - $9.85 $28,535 - $34,445	3,497 Added 211.43%	5,151 $42,000
Q4 2024 Feb 07, 2025	SELL	$9.36 - $12.01 $10,951 - $14,051	-1,170 Reduced 41.43%	1,654 $15,000
Q3 2024 Nov 08, 2024	BUY	$9.55 - $12.09 $3,543 - $4,485	371 Added 15.12%	2,824 $30,000

Q2 2024 Aug 09, 2024	SELL	$9.04 - $11.75 $4,465 - $5,804	-494 Reduced 16.76%	2,453 $24,000
Q1 2024 May 10, 2024	BUY	$11.43 - $14.24 $16,824 - $20,961	1,472 Added 99.8%	2,947 $34,000
Q4 2023 Feb 09, 2024	BUY	$9.97 - $14.52 $1,944 - $2,831	195 Added 15.23%	1,475 $20,000
Q4 2022 Feb 10, 2023	BUY	$9.89 - $12.7 $12,659 - $16,256	1,280 New	1,280 $15,000
Q2 2022 Aug 12, 2022	SELL	$6.23 - $11.12 $585 - $1,045	-94 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$8.71 - $10.72 $13,753 - $16,926	-1,579 Reduced 94.38%	94 $0
Q1 2021 May 07, 2021	BUY	$9.2 - $23.86 $1,472 - $3,817	160 Added 10.58%	1,673 $16,000
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $10,223 - $18,891	-759 Reduced 33.41%	1,513 $34,000
Q3 2020 Nov 06, 2020	BUY	$12.89 - $15.89 $17,092 - $21,070	1,326 Added 140.17%	2,272 $32,000
Q2 2020 Aug 07, 2020	SELL	$8.86 - $15.69 $540 - $957	-61 Reduced 6.06%	946 $14,000
Q1 2020 May 08, 2020	BUY	$6.63 - $11.16 $6,199 - $10,434	935 Added 1298.61%	1,007 $9,000
Q4 2019 Feb 07, 2020	SELL	$7.48 - $10.75 $909,216 - $1.31 Million	-121,553 Reduced 99.94%	72 $0
Q3 2019 Nov 08, 2019	SELL	$8.02 - $13.25 $400,574 - $661,797	-49,947 Reduced 29.11%	121,625 $975,000
Q2 2019 Aug 09, 2019	SELL	$10.96 - $14.4 $948,029 - $1.25 Million	-86,499 Reduced 33.52%	171,572 $0
Q1 2019 May 10, 2019	BUY	$10.04 - $13.92 $2.59 Million - $3.59 Million	258,071 New	258,071 $0
Q4 2018 Feb 08, 2019	SELL	$8.38 - $13.44 $49,198 - $78,906	-5,871 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$11.6 - $16.54 $1.02 Million - $1.46 Million	-88,222 Reduced 93.76%	5,871 $0
Q2 2018 Aug 10, 2018	SELL	$13.13 - $17.09 $371,959 - $484,142	-28,329 Reduced 23.14%	94,093 $0
Q1 2018 May 11, 2018	SELL	$13.76 - $17.12 $83,605 - $104,021	-6,076 Reduced 4.73%	122,422 $0
Q4 2017 Feb 09, 2018	SELL	$12.51 - $16.24 $800,927 - $1.04 Million	-64,023 Reduced 33.26%	128,498 $0
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $2.26 Million - $3.04 Million	192,521	192,521 $0

Others Institutions Holding FOLD

# of Institutions

323

Shares Held

323M

Call Options Held

1.09M

Put Options Held

1.04M

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.66B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Amicus Therapeutics, Inc. Transaction History